| Literature DB >> 36075810 |
Kristien Coteur1, Catharina Matheï2, Birgitte Schoenmakers2, Marc Van Nuland2.
Abstract
BACKGROUND: Sleep disorders, including insomnia, are widespread problems, which have increased during the COVID-19 pandemic. Guidelines for the treatment of insomnia prioritize non-pharmacological interventions. Nevertheless, primary care professionals lack well-developed material for patient education, that could help implement the treatment guidelines in Flanders, Belgium.Entities:
Keywords: Co-design; General practice; Insomnia; Patient education; Patient involvement; Patient-centered design; Primary health care research
Year: 2022 PMID: 36075810 PMCID: PMC9425708 DOI: 10.1016/j.pec.2022.08.018
Source DB: PubMed Journal: Patient Educ Couns ISSN: 0738-3991
Premises for discussion in mini focus groups, based upon previous literature review and findings from think-aloud studies.
| Premises |
|---|
Offering non-pharmacological interventions can only be done by the general practitioner. Currently, we are handling insomnia adequately in primary care. With a leaflet or website of good quality, patients can cope on their own. The already existing material is sufficient. |
Demographic data of participants (data from earliest phase of participation used if participated in multiple pre-design phases).
| Healthcare professionals (n=15) | Survey participants (n=21) | ||
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 44.00 (14.73) | 41.60 (12.73) | 39 (12.54) |
| Range | 24 - 68 | 25 – 60 | 25 - 62 |
| Sex, n (%) | |||
| Male | 3 (30.00) | 7 (46.67) | 7 (33.33) |
| Female | 7 (70.00) | 8 (53.33) | 14 (66.67) |
Number of participants in each phase of the project (TAS= think-aloud studies; M-FG=mini focus groups; DS= design studio).
| Pre-design 1.A.TAS | Pre-design 1.B.M-FG | Generative 2.DS | Evaluative 3.TAS | Post-design 4.Evaluation survey | |
|---|---|---|---|---|---|
| 6 | NA | 2 | 4 | NA | |
| General practitioner/MD (n=4)* | NA | 3 | 2 | 2 | 17 |
| Pharmacist (n=2)* | NA | 2 | 1 | 1 | 2 |
| Psychologist/psychiatrist (n=4)* | NA | 3 | 2 | 2 | 2 |
| Physiotherapist (n=4)* | NA | 4 | NA | 1 | NA |
| Nurse (n=1)* | NA | 1 | 1 | 1 | NA |
*n represents the total number of unique participants in this category who participated in phases 1 to 3
Insomnia and health literacy in the co-design participant sample for each phase of the project (TAS= think-aloud studies; M-FG=mini focus groups; DS= design studio).
| 1.A. TAS | 1.B. M-FG | 2. | 3. | |
|---|---|---|---|---|
| n | 6 | 13 | 8 | 11 |
| ISI score | ||||
| Mean (SD) | 16 (4.23) | 6 (4.35) | 10 (7.71) | 13 (7.72) |
| Range | 9-22 | 0-15 | 3-26 | 2-25 |
| Clinical outcome, n (%) | ||||
| No clinically significant insomnia | - | 8 (61.54) | 4 (50.00) | 3 (27.27) |
| Mild to moderate insomnia | 2 (33.33) | 4 (30.77) | 2 (25.00) | 3 (27.27) |
| Moderate insomnia | 3 (50.00) | 1 (7.69) | 1 (12.50) | 4 (36.36) |
| Severe insomnia | 1 (16.67) | - | 1 (12.50) | 1 (9.09) |
| HLS-EU-Q16 score | ||||
| Mean (SD) | 13 (3.08) | 15 (1.89) | 14 (4.56) | 14 (2.81) |
| Range | 9-16 | 11-16 | 3-16 | 8-16 |
| Clinical outcome, n (%) | ||||
| Inadequate | - | - | 1 (12.50) | 1 (9.09) |
| Problematic | 2 (33.33) | 3 (23.08) | - | 2 (18.18) |
| Adequate | 4 (66.67) | 10 (76.92) | 7 (87.50) | 8 (72.73) |
Fig. ISummary of the development and implementation process; pre-design phases 1 A and 1B, generative phase: 2, evaluative phase: 3, post-design phase: 4, following the co-design framework of Sanders and Stappers (2014).
Premises for discussion in mini focus groups, based upon previous literature review and findings from think aloud studies.
| Premises |
|---|
Offering non-pharmacological interventions can only be done by the general practitioner. Currently, we are handling insomnia adequately in primary care. With a leaflet or website of good quality, patients can cope on their own. The already existing material is sufficient. |
Demographic data of participants (data from earliest phase of participation used if participated in multiple phases).
| Patients (n=10) | Healthcare professionals (n=15) | Survey participants (n=21) | |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 44.00 (14.73) | 41.60 (12.73) | 39 (12.54) |
| Range | 24 - 68 | 25 – 60 | 25 - 62 |
| Sex, n (%) | |||
| Male | 3 (30.00) | 7 (46.67) | 7 (33.33) |
| Female | 7 (70.00) | 8 (53.33) | 14 (66.67) |
Number of participants in each phase of the project (TAS= think-aloud studies; M-FG=mini focus groups; DS= design studio).
| Pre-design 1.A.TAS | Pre-design 1.B.M-FG | Generative 2.DS | Evaluative 3.TAS | Post-design 4.Evaluation survey | |
|---|---|---|---|---|---|
| Patient (n=10)* | 6 | NA | 2 | 4 | NA |
| General practitioner/MD (n=4)* | NA | 3 | 2 | 2 | 17 |
| Pharmacist (n=2)* | NA | 2 | 1 | 1 | 2 |
| Psychologist/psychiatrist (n=4)* | NA | 3 | 2 | 2 | 2 |
| Physiotherapist (n=4)* | NA | 4 | NA | 1 | NA |
| Nurse (n=1)* | NA | 1 | 1 | 1 | NA |
*n represents the total number of unique participants in this category who participated in at least one research phase of the project
Insomnia and health literacy in the co-design participant sample for each phase of the project (TAS= think-aloud studies; M-FG=mini focus groups; DS= design studio).
| 1.A. TAS | 1.B. M-FG | 2. | 3. | |
|---|---|---|---|---|
| n | 6 | 13 | 8 | 11 |
| ISI score | ||||
| Mean (SD) | 16 (4.23) | 6 (4.35) | 10 (7.71) | 13 (7.72) |
| Range | 9-22 | 0-15 | 3-26 | 2-25 |
| Clinical outcome, n (%) | ||||
| No clinically significant insomnia | - | 8 (61.54) | 4 (50.00) | 3 (27.27) |
| Mild to moderate insomnia | 2 (33.33) | 4 (30.77) | 2 (25.00) | 3 (27.27) |
| Moderate insomnia | 3 (50.00) | 1 (7.69) | 1 (12.50) | 4 (36.36) |
| Severe insomnia | 1 (16.67) | - | 1 (12.50) | 1 (9.09) |
| HLS-EU-Q16 score | ||||
| Mean (SD) | 13 (3.08) | 15 (1.89) | 14 (4.56) | 14 (2.81) |
| Range | 9-16 | 11-16 | 3-16 | 8-16 |
| Clinical outcome, n (%) | ||||
| Inadequate | - | - | 1 (12.50) | 1 (9.09) |
| Problematic | 2 (33.33) | 3 (23.08) | - | 2 (18.18) |
| Adequate | 4 (66.67) | 10 (76.92) | 7 (87.50) | 8 (72.73) |